Advertisement

Topics

$417 Million Awarded in Suit Tying Johnson’s Baby Powder to Cancer

00:12 EDT 22 Aug 2017 | The New York Times News

A Los Angeles jury voted the damages for a medical receptionist who developed ovarian cancer after using Johnson & Johnson’s talc for decades.

Original Article: $417 Million Awarded in Suit Tying Johnson’s Baby Powder to Cancer

NEXT ARTICLE

More From BioPortfolio on "$417 Million Awarded in Suit Tying Johnson’s Baby Powder to Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...